Results 1 to 1 of 1

Thread: Genetic mechanisms of critical illness in Covid-19

  1. #1
    Registered Users
    Posts
    1,413
    Sex
    Location
    Glasgow, Scotland
    Ethnicity
    Pictland/Deira
    Y-DNA (P)
    R1b-M222-FGC5864
    mtDNA (M)
    H5r*

    Genetic mechanisms of critical illness in Covid-19

    This just out in Nature.

    Pairo-Castineira, E., Clohisey, S., Klaric, L. et al. Genetic mechanisms of critical illness in Covid-19. Nature (2020). https://doi.org/10.1038/s41586-020-03065-y

    Host-mediated lung inflammation is present,1 and drives mortality,2 in critical illness caused by Covid-19. Host genetic variants associated with critical illness may identify mechanistic targets for therapeutic development.3 Here we report the results of the GenOMICC (Genetics Of Mortality In Critical Care) genome-wide association study(GWAS) in 2244 critically ill Covid-19 patients from 208 UK intensive care units (ICUs). We identify and replicate novel genome-wide significant associations, on chr12q24.13 (rs10735079, p=1.65 × 10-8) in a gene cluster encoding antiviral restriction enzyme activators (OAS1, OAS2, OAS3), on chr19p13.2 (rs2109069, p=2.3 × 10-12) near the gene encoding tyrosine kinase 2 (TYK2), on chr19p13.3 (rs2109069, p=3.98 × 10-12) within the gene encoding dipeptidyl peptidase 9 (DPP9), and on chr21q22.1 (rs2236757, p=4.99 × 10-8) in the interferon receptor gene IFNAR2. We identify potential targets for repurposing of licensed medications: using Mendelian randomisation we found evidence in support of a causal link from low expression of IFNAR2, and high expression of TYK2, to life-threatening disease; transcriptome-wide association in lung tissue revealed that high expression of the monocyte/macrophage chemotactic receptor CCR2 is associated with severe Covid-19. Our results identify robust genetic signals relating to key host antiviral defence mechanisms, and mediators of inflammatory organ damage in Covid-19. Both mechanisms may be amenable to targeted treatment with existing drugs. Large-scale randomised clinical trials will be essential before any change to clinical practice.


    https://www.nature.com/articles/s41586-020-03065-y
    YSEQ:#37; YFull: YF01405 (Y Elite 2013)
    WGS (Full Genomes Nov 2015, YSEQ Feb 2019, Dante Mar 2019, FGC-10X Linked Reads Apr 2019, Dante-Nanopore May 2019, Chronomics Jan 2020, Sano Genetics Feb 2020, Nebula Genomics June 2020)
    Ancestry GCs: Scots in central Scotland & Ulster, Ireland; English in Yorkshire & Pennines
    Hidden Content
    FBIMatch: A------ (autosomal DNA) for segment matching DO NOT POST ADMIXTURE REPORTS USING MY KIT

  2. The Following 3 Users Say Thank You to MacUalraig For This Useful Post:

     Frank&Frei (12-16-2020),  Megalophias (12-12-2020),  Webb (12-12-2020)

Similar Threads

  1. COVID 19
    By ffoucart in forum French
    Replies: 383
    Last Post: 11-22-2020, 09:13 PM
  2. Replies: 1
    Last Post: 06-22-2020, 01:47 PM
  3. Replies: 2
    Last Post: 03-29-2019, 03:11 PM
  4. Philosophy and Mechanisms of Evolution
    By Ric in forum Human Evolution
    Replies: 59
    Last Post: 06-22-2017, 03:34 PM

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •